@article{c1a3ce97f58d414a8860abf15cc0f291,
title = "BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A validation study",
keywords = "BAP1, Chemotherapy, Pemetrexed, Pleural mesothelioma, Predictive biomarkers",
author = "Amber Louw and Vasiliki Panou and Szejniuk, {Weronika Maria} and Christos Meristoudis and Chai, {Siaw Ming} and {van Vliet}, Chris and Lee, {Y. C. Gary} and Dick, {Ian M.} and Tina Firth and Lynggaard, {Louise Andersen} and Asghari, {Azadeh Birbaneh} and Mogens Vyberg and Johnni Hansen and Jenette Creaney and R{\o}e, {Oluf Dimitri}",
note = "Copyright {\textcopyright} 2022 International Association for the Study of Lung Cancer. All rights reserved.",
year = "2022",
month = apr,
day = "27",
doi = "10.1016/j.jtho.2022.04.008",
language = "English",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier",
}